Company News

FDA in India Serves Notice to Wipro

MUMBAI: The Maharashtra Food and Drug Administration (FDA) served a notice to Wipro for allegedly “misbranding and mislabeling” its baby oil.
“We have served notice to Wipro for misbranding and labeling deficiency or mislabeling its baby oil manufactured under the name Wipro Baby Soft,” FDA commissioner A. Ramkrishnan said.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters